Literature DB >> 10664248

The two-receptor system PAR-1/PAR-4 mediates alpha-thrombin-induced [Ca(2+)](i) mobilization in human astrocytoma cells.

R Kaufmann1, S Patt, M Zieger, R Kraft, S Tausch, P Henklein, G Nowak.   

Abstract

The proteinase-activated receptor 1 (PAR-1) was characterized as a functional receptor for thrombin in cells from different brain tumor entities. Whether PAR-1 alone accounts for thrombin-induced effects in human cancer cells, or whether other PAR contribute is unknown. We established primary cultures from two neurosurgically removed human astrocytomas and investigated intracellular signaling roles of PAR-1 and PAR-4 by estimating the effect of alpha-thrombin and PAR-activating peptides on [Ca(2+)](i) mobilization in single astrocytoma cells. alpha-Thrombin or the PAR-1-activating peptide SFLLRN induced a transient calcium mobilization. This suggests the involvement of PAR-1 in alpha-thrombin-induced calcium signaling in human astrocytoma cells. In addition, a second, PAR-4-dependent, mechanism exists. This was deduced from the findings that a further calcium signal could be observed in human astrocytoma cells stimulated with alpha-thrombin after SFLLRN and the PAR-4-activating peptide GYPGQV also induced a calcium response. In addition, the observation that trypsin, known to activate both PAR-2 and PAR-4, but not the specifically PAR-2-activating peptide SLIGRL induced calcium signaling is a further indication of functional PAR-4-type thrombin receptors in human astrocytoma cells. This is the first report demonstrating a signaling role for a dual thrombin receptor system in human tumor cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10664248     DOI: 10.1007/pl00008481

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  7 in total

Review 1.  Protease-activated receptors: regulation of neuronal function.

Authors:  Toshiyuki Saito; Nigel W Bunnett
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

Review 2.  Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more.

Authors:  R Ramachandran; M D Hollenberg
Journal:  Br J Pharmacol       Date:  2007-12-03       Impact factor: 8.739

3.  Evidence for functionally active protease-activated receptor-4 (PAR-4) in human vascular smooth muscle cells.

Authors:  E Bretschneider; R Kaufmann; M Braun; G Nowak; E Glusa; K Schrör
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

Review 4.  Expression of proteinase-activated receptor 1-4 (PAR 1-4) in human cancer.

Authors:  Andrea Pia Elste; Iver Petersen
Journal:  J Mol Histol       Date:  2010-06-20       Impact factor: 2.611

5.  Expression of functional protease-activated receptor 1 in human prostate cancer cell lines.

Authors:  Jian Liu; Manuela Bastian; Peter Kohlschein; Peter Schuff-Werner; Michael Steiner
Journal:  Urol Res       Date:  2003-03-25

Review 6.  Role of the protease-activated receptor 1 in regulating the function of glial cells within central and peripheral nervous system.

Authors:  Elena Pompili; Cinzia Fabrizi; Francesco Fornai; Lorenzo Fumagalli
Journal:  J Neural Transm (Vienna)       Date:  2019-09-06       Impact factor: 3.575

Review 7.  Proteinase-activated receptors (PARs) - focus on receptor-receptor-interactions and their physiological and pathophysiological impact.

Authors:  Frank Gieseler; Hendrik Ungefroren; Utz Settmacher; Morley D Hollenberg; Roland Kaufmann
Journal:  Cell Commun Signal       Date:  2013-11-11       Impact factor: 5.712

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.